Back to Search
Start Over
A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy.
- Source :
-
Clinical and experimental dermatology [Clin Exp Dermatol] 2008 Mar; Vol. 33 (2), pp. 154-5. Date of Electronic Publication: 2007 Nov 16. - Publication Year :
- 2008
-
Abstract
- Several cases of psoriasis associated with bullous disorders have been reported, and it is clearly recognized that bullous pemphigoid (BP) is the most common bullous disorder observed in association with psoriasis, especially after ultraviolet (UV)B and psoralen UVA therapy. Moreover, other medications have been repeatedly reported to induce bullous diseases, especially pemphigus vulgaris. We report for the first time a case of BP possibly induced by losartan, an angiotensin II antagonist, in a patient with a severe psoriatic background. Angiotensin II type 1 receptor antagonists belong to a new class of drug for hypertension or congestive heart failure with established efficacy and few side-effects. Coexistence of psoriasis vulgaris with bullous diseases represents also a difficult therapeutic challenge. This rare case of psoriasis and generalized BP triggered by a sartan drug was treated with rituximab and etanercept.
- Subjects :
- Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal, Murine-Derived
Drug Eruptions etiology
Drug Eruptions pathology
Humans
Immunologic Factors therapeutic use
Male
Middle Aged
Pemphigoid, Bullous pathology
Psoriasis pathology
Rituximab
Treatment Outcome
Angiotensin II Type 1 Receptor Blockers adverse effects
Losartan adverse effects
Pemphigoid, Bullous chemically induced
Psoriasis drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0307-6938
- Volume :
- 33
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Clinical and experimental dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 18021271
- Full Text :
- https://doi.org/10.1111/j.1365-2230.2007.02603.x